FDA Drug Approval, N017381, SILVADENE

NDA: 017381
Company: KING PHARMS LLC
Drug Name: SILVADENE
Active Ingredients: SILVER SULFADIAZINE
Strength: 1%
Dosage Form/Route: CREAM;TOPICAL
Action Date: 11/26/1973
Marketing Status: Prescription
Submission Classification: Type 2 - New Active Ingredient

118 pages including Approval Letter, Final Printed Label, Medical Officer's Review, Chemist's Review, Pharmacologist's Review, Microbiologist's Review, Supplements, SBA